Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Lysimachia christinae granules to prevent recurrence after renal/ureteral stone surgery
ChiCTR2300070748Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Apr 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Lithiasis comparing Compound Lysimachia christinae Hance granules with Placebo granules (2 arms). Primary endpoint: Maximum diameter of recurrent stone. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
compound herba lysimachiae granules
03
Conditions
Lithiasis
Beyond the preview
Go deeper on ChiCTR2300070748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070748.